Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1, Two-part, Multicenter, Open-label, Multiple Dose, First-in-human Study of DS-1062a in Subjects With Advanced Solid Tumors (TROPION-PanTumor01)

NCT03401385 is registered in ClinicalTrials.gov with Daiichi Sankyo Co., Ltd. as lead sponsor.

NCT NCT03401385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03401385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1, Two-part, Multicenter, Open-label, Multiple Dose, First-in-human Study of DS-1062a in Subjects With Advanced Solid Tumors (TROPION-PanTumor01)
Lead sponsor
Daiichi Sankyo Co., Ltd.
Phase
Phase 1
Overall status
Active, not recruiting
Start date
January 31, 2018
Completion date
January 1, 2028
Enrollment
890 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hormone receptor positive breast cancer, non-small cell lung cancer, triple negative breast cancer